Autolus Therapeutics
AUTL
48 hedge funds and large institutions have $113M invested in Autolus Therapeutics in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
4% more funds holding
Funds holding: 46 → 48 (+2)
6% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 16
0.4% more ownership
Funds ownership: 23.71% → 24.11% (+0.4%)
21% less capital invested
Capital invested by funds: $142M → $113M (-$29M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$3.42M |
| 2 |
EP
Eversept Partners
New York
|
+$1.65M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
+$1.14M |
| 4 |
Morgan Stanley
New York
|
+$997K |
| 5 |
JP Morgan Chase
New York
|
+$806K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$3.32M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$1.37M |
| 3 |
Millennium Management
New York
|
-$1.25M |
| 4 |
Two Sigma Investments
New York
|
-$386K |
| 5 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$339K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Acadian Asset Management
Boston,
Massachusetts
| – | -$24K | -2,062 | Closed |
|
|
AWA
52
Arkadios Wealth Advisors
Atlanta,
Georgia
| – | +$501 | +47 | New |
|
AUTL Hedge Fund Activity: Q4 2020 in Review
48 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Autolus Therapeutics (AUTL) for Q4 2020, worth a combined $113M — down 21% from $142M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new AUTL positions and 4 closed out — a net gain of 2 holders — while 17 added to existing stakes and 16 trimmed.
The largest buyer was Baker Bros. Advisors, adding an estimated $3.42M. The largest seller was Artal Group, exiting entirely with an estimated $3.32M sold.
- 48 institutional investors held Autolus Therapeutics (AUTL) as of Q4 2020, up from 46 in Q3 2020.
- Funds reported $113M of Autolus Therapeutics stock for Q4 2020, down 21% quarter-over-quarter.
- 6 funds opened new Autolus Therapeutics positions in Q4 2020 and 4 closed out, a net change of +2 holders.
- The largest Autolus Therapeutics buyer in Q4 2020 was Baker Bros. Advisors, an estimated $3.42M added.
- The largest Autolus Therapeutics seller in Q4 2020 was Artal Group, an estimated $3.32M sold.
Based on aggregated 13F filings for Q4 2020.